Thus, our data indicated that K284 blocks the formation of the CHI3L1/IL‐13Rα2 complex and the downstream signaling of JNK, AKT, and AP‐1 pathways leading to the inhibition of cancer cell growth. The gene discussed is CHI3L1; the disease is cancer.